InsiderTrades

Form 4 for BEAM Beam Therapeutics Inc.

Accepted 2024-10-16 00:00:00 ET · period of report 2024-10-14 · accession 0000950170-24-115031 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMT 2024-10-16 2024-10-14 BEAM Ciaramella Giuseppe Pres M - OptEx $2.00 +41.8K 209.9K +25% +$83.6K
DT 2024-10-16 2024-10-14 BEAM Ciaramella Giuseppe Pres S - Sale+OE $26.27 -51.1K 160.3K -24% -$1.34M
DMT 2024-10-16 2024-10-14 BEAM Ciaramella Giuseppe Pres M - OptEx $0.00 -41.8K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-10-14 M A 27,318 $0.67 196,934 D — —
2 Common Common Stock 2024-10-14 S D 51,110 $26.27 160,260 D — — (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.00 to $26.56, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
3 Common Common Stock 2024-10-14 M A 1,457 $7.22 211,370 D — —
4 Common Common Stock 2024-10-14 M A 12,979 $4.22 209,913 D — —
5 Derivative Stock Option (Right to Buy) 2024-10-14 M D 12,979 $0.00 0 D $4.22 · 2024-04-03 to 2029-02-13 12,979 Comon Stock
6 Derivative Stock Option (Right to Buy) 2024-10-14 M D 1,457 $0.00 0 D $7.22 · — to 2029-05-31 1,457 Comon Stock (F4) This stock option vested as to 25% on the first anniversary of the vesting commencement date, October 1, 2019, and at a rate of 2.78% each month thereafter until the option was fully vested.
7 Derivative Stock Option (Right to Buy) 2024-10-14 M D 27,318 $0.00 0 D $0.67 · 2024-04-03 to 2028-05-08 27,318 Comon Stock